Synthesis and in vitro cytotoxicity of cinnamaldehydes to human solid tumor cells

Archives of Pharmacal Research

Volumn 21, Issue 2, 1998, Pages 147-152

  Kwon, Byoung Mog ^a   Lee, Seung Ho ^a   Choi, Sang Un ^c   Park, Sung Hee ^c   Lee, Chong Ock ^c   Cho, Young Kwon ^b   Sung, Nack Do ^b   Bok, Song Hae ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Cinnamaldehyde; Cinnamomum cassia; Cytotoxicity; Human tumor cell

Indexed keywords

ACROLEIN; ANTINEOPLASTIC AGENT; CINNAMALDEHYDE; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;

ALKYLATION; ARTICLE; CELL CULTURE; HUMAN; INFRARED SPECTROSCOPY; SYNTHESIS; ULTRAVIOLET SPECTROPHOTOMETRY;

ACROLEIN; ALKYLATION; ANTINEOPLASTIC AGENTS, PHYTOGENIC; HUMANS; INDICATORS AND REAGENTS; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TUMOR CELLS, CULTURED;

EID: 0032034869     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02974019     Document Type: Article

References (9)

1. Billman, J. H. and Tonnis, J. A., Substituted aralkyl aldehydes: preparation and antitumor evaluation. J Pharm. Sci., 60, 1188-1192 (1971).
2. Dornish, J. M., Petterson, E. O. and Oftebro, R., Modifying effect of cinnamaldehyde and cinnamaldehyde derivatives on cell inactivation and cellular uptake of cis-diamminedichloroplatinum (II) in human NHIK 3025 cells. Cancer Res., 49, 3917-3921 (1989).
3. Goldin, A., Serpick, A. A., Mantel, N., Experimental screening procedures and clinical predictability value. Cancer Chemoth. Rep., 50, 190-231(1966).
4. Kwon, B. M., Cho, Y. K., Lee, S. H., Nam, J. Y., Bok, S. H., Chun, S. K., Kim, J. A. and Lee, I. R., 2′-Hydroxycinnamaldehyde from stem bark of cinnamomum cassia. Planta Med. 62, 193-184 (1996).
5. Kwon, B. M., Lee, S. H., Cho, Y. K., Bok, S. H., So, S. H., Youn, M. R. and Chang, S. I., Synthesis and biological activity of cinnamaldehydes as angiogenesis inhibitors. Bioorg. Med. Chem. Letters, 7, 2473-2476 (1997).
6. Rutten, B. and Gocke, E., The antimutagenic of cinnamaldehyde is due to a transient growth inhibition. Mutation Res. 201, 97-105 (1988).
7. Piantadosi, C., Skulason, V. G., Irvin, J. L., Powell, J. M. and Hall, L., Potential antitumor agents. Schiffbases and hydrazone derivatives of pyrimidine-4-carboxaldehydes. J. Med. Chem., 7, 337-348 (1964).
8. Ryu, S. Y., Choi, S. U., Lee, C. O. and Zee, O. P., Anticancer activity of psoralea corylifolia. Arch. Pharm. Res., 15, 356-359 (1992).
9. Skehan, P. Streng, R. Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warrenm J. T., Bokesch, H., Kenney, S. and Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82, 1107-1112 (1990)